Residual Nonunion in a Case of Two and-a-half Year Old Child Congenital Pseudarthrosis of Ipsilateral Tibia and Fibula Treated by Intramedullary Fixation with K-Wire and Allogenic Cancellous Strut Graft: A Case Report

Authors

  • Siddaram. N. Patil

DOI:

https://doi.org/10.37591/rrjohp.v3i1.834

Abstract

The pseudarthrosis usually develops during the first two years of life; however, there are reports of cases in which fractures developed before birth and reports of late-onset pseudarthrosis. There is a strong association between congenital pseudarthrosis (CPT) and Type I neurofibromatosis. CPT develops in about 5.7% of patients with NF-I and 40% of patients with pseudarthrosis were found to have NF-I. Main pathology is hyperplasia of fibroblasts with the formation of dense fibrous tissue at fracture site causing osteolysis, and persistence of pseudarthrosis. The difficulty in treating this condition occurs because of two factors: (i) Biologic: Poor healing ability of the dysplastic segment of bone and (ii) Mechanical: Technical difficulty to fix small and osteopenic bone fragments in children without damaging the distal physis. A multitude of treatment protocols focusing on stimulating the healing process by using different bone grafting techniques were documented. The graft materials most commonly used included osteoperiosteal graft, massive onlay graft, autogenous iliac crest bone graft, and vascularized bone graft.

 

Keywords: congenital pseudarthrosis, tibia and fibula, nonunion, bone grafting vascularized bone graft

Downloads

Published

2019-03-18

Issue

Vol. 3 No. 1 (2013)

Section

Case Study

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.